CSIMarket



Quest Diagnostics Inc  (DGX)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

DGX's Revenue Growth by Quarter and Year

Quest Diagnostics Inc's Revenue results by quarter and year




DGX Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 2,744.00 3,002.00 1,926.00
III Quarter September - 2,774.00 2,786.00 1,956.00
II Quarter June - 2,550.00 1,827.00 1,953.00
I Quarter March 2,611.00 2,720.00 1,822.00 1,891.00
FY   2,611.00 10,788.00 9,437.00 7,726.00



DGX Revenue first quarter 2022 Y/Y Growth Comment
Quest Diagnostics Inc reported decrease in Revenue in the first quarter 2022 by -4.01% to $ 2,611.00 millions, from the same quarter in 2021.
The decrease in the first quarter 2022 Quest Diagnostics Inc's Revenue compares unfavorably to the Company's average Revenue growth of 4.94%.

Looking into first quarter 2022 results within Medical Laboratories industry 25 other companies have achieved higher Revenue growth. While Quest Diagnostics Inc' s Revenue decline of -4.01% ranks overall at the positon no. 2487 in the first quarter 2022.




DGX Revenue ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - -8.59 % 55.87 % 4.73 %
III Quarter September - -0.43 % 42.43 % 3.55 %
II Quarter June - 39.57 % -6.45 % 1.77 %
I Quarter March -4.01 % 49.29 % -3.65 % 0.37 %
FY   - 14.32 % 22.15 % 2.59 %

Financial Statements
Quest Diagnostics Inc's first quarter 2022 Revenue $ 2,611.00 millions DGX's Income Statement
Quest Diagnostics Inc's first quarter 2021 Revenue $ 2,720.00 millions Quarterly DGX's Income Statement
New: More DGX's historic Revenue Growth >>


DGX Revenue (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - -1.08 % 7.75 % -1.53 %
III Quarter September - 8.78 % 52.49 % 0.15 %
II Quarter June - -6.25 % 0.27 % 3.28 %
I Quarter March -4.85 % -9.39 % -5.4 % 2.83 %
FY (Year on Year)   - 14.32 % 22.15 % 2.59 %




Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #386
Overall #2487

Revenue Y/Y Growth Statistics
High Average Low
55.87 % 4.94 % -8.59 %
(Dec 31 2020)   (Dec 31 2021)
Revenue first quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #26
Healthcare Sector #386
Overall #2487
Revenue Y/Y Growth Statistics
High Average Low
55.87 % 4.94 % -8.59 %
(Dec 31 2020)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Quest Diagnostics Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
52.49 % 1.26 % -9.39 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Quest Diagnostics Inc disclosed fall in Revenue from the forth quarter by -4.85% to $ 2,611.00 millions, from $ 2,744.00 millions achived in the previous quarter.

As we look into present shortcoming in the I. Quarter 2022, we suppose to assume, that frequently I. Quarter performance appear to be softer then in the forth quarter, James Clark, a business observer mentioned.

Within Medical Laboratories industry only one company achieved higher sequential Revenue growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 103.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #11
Overall #103
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #2
Healthcare Sector #11
Overall #103
Revenue Q/Q Growth Statistics
High Average Low
52.49 % 1.26 % -9.39 %
(Sep 30 2020)  


DGX's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2022 Quest Diagnostics Inc reported fall in Revenue sequentially by -4.85% to $ 2,611.00 millions, from $ 2,744.00 millions declared in the previous reporting period.

But that's not huge concern, as Quest Diagnostics Inc's Revenue frequently gravitate to slow in the I. Quarter James Clark, a business observer wrote.

Within Medical Laboratories industry only one company achieved higher sequential Revenue growth. While Quest Diagnostics Inc's Revenue growth quarter on quarter, overall rank is 103.


Quest Diagnostics Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Revenue 12 Months Ending $ 10,679.00 $ 10,788.00 $ 11,046.00 $ 11,058.00 $ 10,335.00
Y / Y Revenue Growth (TTM) 3.33 % 14.32 % 32.11 % 46.83 % 34.97 %
Year on Year Revenue Growth Overall Ranking # 119 # 1967 # 918 # 533 # 20
Seqeuential Revenue Change (TTM) -1.01 % -2.34 % -0.11 % 7 % 9.52 %
Seq. Revenue Growth (TTM) Overall Ranking # 139 # 3149 # 3022 # 1586 # 754




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Revenue were $ 10,679 millions, company would post below average annual Revenue growth of 9.52% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Revenue growth from the 2744% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Revenue growth, were the second highest.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 119, from total ranking in previous quarter at 1967.

Revenue TTM Q/Q Growth Statistics
High Average Low
12.87 %
1.11 %
-2.34 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 5
Overall # 119

Revenue TTM Y/Y Growth Statistics
High Average Low
46.83 %
5.01 %
-5.42 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 11
S&P 500 # 139
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Mar 31 2022 period, Quest Diagnostics Inc's cumulative twelve months Revenue were $ 10,679 millions, company would post below average annual Revenue growth of -5.42% year on year, if the fiscal year would end at Mar 31 2022.
A slow-down in the Quest Diagnostics Inc's Revenue growth from the 2744% growth in Dec 31 2021. Comparing the results with it's peers in Medical Laboratories industry, Quest Diagnostics Inc's trailing twelve months Revenue growth, were the second highest.

Among companies within the Healthcare sector 4 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 119, from total ranking in previous quarter at 1967.

Revenue TTM Q/Q Growth Statistics
High Average Low
12.87 %
1.11 %
-2.34 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry # 2
Healthcare Sector # 5
Overall # 119

Revenue TTM Y/Y Growth Statistics
High Average Low
46.83 %
5.01 %
-5.42 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 11
S&P 500 # 139




Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
DGX's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for DGX's Competitors
Revenue Growth for Quest Diagnostics Inc's Suppliers
Revenue Growth for DGX's Customers

You may also want to know
DGX's Annual Growth Rates DGX's Profitability Ratios DGX's Asset Turnover Ratio DGX's Dividend Growth
DGX's Roe DGX's Valuation Ratios DGX's Financial Strength Ratios DGX's Dividend Payout Ratio
DGX's Roa DGX's Inventory Turnover Ratio DGX's Growth Rates DGX's Dividend Comparisons



Companies with similar Revenue fall for the quarter ending Mar 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2022
Hydrofarm Holdings Group Inc -0.01%$ -0.011 millions
Sage Therapeutics Inc -0.06%$ -0.063 millions
Davita Inc -0.09%$ -0.087 millions
Axogen inc -0.10%$ -0.097 millions
Oncternal Therapeutics Inc -0.27%$ -0.267 millions
Glaukos Corp-0.42%$ -0.422 millions
Collegium Pharmaceutical inc -0.70%$ -0.699 millions
Tenet Healthcare Corp-0.75%$ -0.753 millions
Nevro Corp -0.87%$ -0.867 millions
Antares Pharma Inc -1.25%$ -1.250 millions
Elanco Animal Health Inc-1.37%$ -1.369 millions
Nanostring Technologies Inc -1.70%$ -1.698 millions
Mimedx Group Inc -1.79%$ -1.789 millions
Exagen Inc -1.82%$ -1.823 millions
Royalty Pharma Plc-1.92%$ -1.916 millions
Veru Inc -2.34%$ -2.339 millions
Delcath Systems Inc -2.58%$ -2.577 millions
Ikena Oncology Inc -2.59%$ -2.591 millions
Ngm Biopharmaceuticals Inc -2.91%$ -2.906 millions
Livanova Plc-3.00%$ -3.000 millions
Lifevantage Corp-3.04%$ -3.037 millions
Reata Pharmaceuticals Inc -3.18%$ -3.178 millions
Bio rad Laboratories Inc -3.68%$ -3.678 millions
Codiak Biosciences Inc -3.69%$ -3.692 millions
Vanda Pharmaceuticals Inc -3.95%$ -3.953 millions
Quest Diagnostics Inc-4.01%$ -4.007 millions
Organogenesis Holdings Inc -4.32%$ -4.325 millions
Myriad Genetics Inc -4.74%$ -4.737 millions
Bausch Health Companies Inc -5.38%$ -5.377 millions
Viatris Inc -5.39%$ -5.386 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MOHO's Profile

Stock Price

MOHO's Financials

Business Description

Fundamentals

Charts & Quotes

MOHO's News

Suppliers

MOHO's Competitors

Customers & Markets

Economic Indicators

MOHO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071